Healthcare Realty Trust Incorporated (HR)
(Delayed Data from NYSE)
$13.79 USD
+0.06 (0.44%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $13.81 +0.02 (0.15%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.79 USD
+0.06 (0.44%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $13.81 +0.02 (0.15%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
Zacks News
Healthcare Realty Trust (HR) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Healthcare Realty Trust (HR) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Healthcare Realty Trust (HR) Q4 FFO and Revenues Miss Estimates
by Zacks Equity Research
Healthcare Realty Trust (HR) delivered FFO and revenue surprises of -2.50% and 2.94%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Seeking Clues to Healthcare Realty Trust (HR) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Healthcare Realty Trust (HR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Healthcare Realty Trust (HR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Healthcare Realty Trust (HR) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthcare Realty Trust (HR) Q3 FFO Match Estimates
by Zacks Equity Research
Healthcare Realty Trust (HR) delivered FFO and revenue surprises of 0% and 0.38%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Capstar Financial (CSTR) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Capstar Financial (CSTR) delivered earnings and revenue surprises of 19.44% and 8.34%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Compared to Estimates, Healthcare Realty Trust (HR) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Healthcare Realty Trust (HR) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthcare Realty Trust (HR) Lags Q2 FFO Estimates
by Zacks Equity Research
Healthcare Realty Trust (HR) delivered FFO and revenue surprises of -2.50% and 1.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Sabra Healthcare (SBRA) Q2 FFO Meet Estimates
by Zacks Equity Research
Sabra (SBRA) delivered FFO and revenue surprises of 0% and 1.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
DiamondRock Hospitality (DRH) Q2 FFO and Revenues Miss Estimates
by Zacks Equity Research
DiamondRock Hospitality (DRH) delivered FFO and revenue surprises of -5.88% and 1.58%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Vornado (VNO) Surpasses Q2 FFO and Revenue Estimates
by Zacks Equity Research
Vornado (VNO) delivered FFO and revenue surprises of 12.50% and 7.27%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Healthcare Realty (HR) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Healthcare Realty (HR) stock based on the movements in the options market lately.
Healthcare Realty Trust (HR) Lags Q1 FFO and Revenue Estimates
by Zacks Equity Research
Healthcare Realty Trust (HR) delivered FFO and revenue surprises of -2.44% and 0.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Diversified Healthcare (DHC) Matches Q1 FFO Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of 0% and 0.79%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Community Healthcare Trust (CHCT) Tops Q1 FFO and Revenue Estimates
by Zacks Equity Research
Community Healthcare Trust (CHCT) delivered FFO and revenue surprises of 10.71% and 2.79%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
W.P. Carey (WPC) Misses Q1 FFO Estimates
by Zacks Equity Research
W.P. Carey (WPC) delivered FFO and revenue surprises of -0.76% and 1.90%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
How Much Upside is Left in Healthcare Realty Trust (HR)? Wall Street Analysts Think 34.48%
by Zacks Equity Research
The mean of analysts' price targets for Healthcare Realty Trust (HR) points to a 34.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Healthcare Realty Trust (HR) Surpasses Q4 FFO Estimates
by Zacks Equity Research
Healthcare Realty Trust (HR) delivered FFO and revenue surprises of 5% and 4.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Alexander & Baldwin Holdings, Inc. (ALEX) Q4 FFO Top Estimates
by Zacks Equity Research
Alexander & Baldwin Holdings, Inc. (ALEX) delivered FFO and revenue surprises of 29.17% and 27.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Extra Space Storage (EXR) Tops Q4 FFO and Revenue Estimates
by Zacks Equity Research
Extra Space Storage (EXR) delivered FFO and revenue surprises of 0.48% and 2.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Public Storage (PSA) Surpasses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Public Storage (PSA) delivered FFO and revenue surprises of 4.26% and 0.87%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Should iShares Morningstar SmallCap ETF (ISCB) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCB
Healthcare Realty Trust (HR) Q2 FFO Match Estimates
by Zacks Equity Research
Healthcare Realty Trust (HR) delivered FFO and revenue surprises of 0% and 28%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Iron Mountain (IRM) Beats Q2 FFO Estimates
by Zacks Equity Research
Iron Mountain (IRM) delivered FFO and revenue surprises of 1.09% and 0.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Q2 FFO Miss Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -3.85% and 5.91%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?